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926Objective: An in vivo study of piglets on cardiopulmonary bypass was performed to determine whether post-
conditioning has a cardioprotective effect after cardioplegic arrest in large animals.
Methods: Eighteen piglets were subjected to 90 minutes of cardioplegic arrest followed by 30 minutes of reper-
fusion. In 6 animals (control), there was no intervention at reperfusion. In 6 other animals, 6 cycles of unclamp-
ing and reclamping for 10 seconds each were done before reperfusion (postconditioning 10), whereas 3 cycles of
unclamping and reclamping for 30 seconds each were performed in another 6 piglets (postconditioning 30).
Results: Recovery of left ventricular contractility and diastolic function (percent of preischemic value) was sig-
nificantly better in both postconditioning groups (contractility: 89.2% and 118.2; diastolic function: 142.3%
and 120.4; in the postconditioning 10 and 30 groups, respectively) compared with the control (contractility:
46.1%; diastolic function: 218.5%). Recovery of global cardiac function (ventricular function curve analysis)
was improved only in the postconditioning 30 group. Troponin-T release during reperfusion was significantly
reduced in the postconditioning 10 group compared with all groups (plasma troponin-Twas 0.58 ng/mL in post-
conditioning 10, 1.85 in postconditioning 30, and 2.54 in control). The myocardial lipid peroxide was signifi-
cantly higher in the control group than in both postconditioning groups after reperfusion (199% vs 112%
and 131%).
Conclusions: Both postconditioning algorisms promoted functional recovery after cardioplegic arrest in a large
animal model along with the limitation of lipid peroxidation with or without the reduction of troponin-T release.
(J Thorac Cardiovasc Surg 2011;142:926-32)In 2003, ischemic postconditioning was first introduced by
Zhao and associates1 as a potent method of endogenous
cardioprotection against ischemia–reperfusion injury. Post-
conditioning by several brief cycles of coronary artery reper-
fusion and reocclusion, when performed immediately at the
onset of reperfusion, has a universally protective effect
against myocardial infarction in coronary ligation models.1-4
However, the influence of postconditioning on another
major consequence of ischemia–reperfusion injury, that is,
myocardial dysfunction, is still controversial. In an in vivo
coronary ligation model, postconditioning did not show any
protective effect against deterioration of regional and global
cardiac function parameters, such as left ventricular (LV)
end-diastolic pressure (LVEDP), the maximum positive and
negative derivatives of LV pressure (dP/dt max), systolic
shortening, and segmental work, despite an infarct-sparinge Department of Cardiac Surgery, Jikei University School of Medicine,
, Japan.
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The Journal of Thoracic and Cardiovascular Surgeffect being consistently observed in various species (dogs,1
rats,2 and rabbits5). Another study that used a short ischemic
period (10 minutes) failed to demonstrate any antistunning
effect of postconditioning on depressed regional wall motion
(LV wall thickening in dogs or segmental shortening
in rabbits).3 More recently, a beneficial effect of postcondi-
tioning on LV function after 30 minutes of global ischemia
(þdP/dt max, LVEDP, and recovery of developed LV pres-
sure) was demonstrated in an isolated rat heart preparation.4,6
However, the value of postconditioning in large animals
subjected to cardioplegic arrest of a longer duration while
supported by cardiopulmonary bypass (CPB) has not been
investigated.
Therefore, we conducted a study of postconditioning in
the surgical setting that focused on protection against post-
ischemic myocardial dysfunction. Our purpose was to as-
sess the cardioprotective effect of postconditioning after
prolonged cardioplegic arrest in piglets on CPB and to de-
termine the impact of different postconditioning algorithms
on LV functional recovery.MATERIALS AND METHODS
All experimental animals received humane care in compliance with the
‘‘Guide for the Care and Use of Laboratory Animals’’ (National Institutes
of Health Publication No. 85-23, revised 1996).ery c October 2011
Abbreviations and Acronyms
CPB ¼ cardiopulmonary bypass
dP/dt
max
¼ maximum positive and negative
derivatives of left ventricular pressure
Ees ¼ end-systolic elastance
LAP ¼ left atrial pressure
LV ¼ left ventricular
LVEDP ¼ left ventricular end-diastolic pressure
LVSWI ¼ left ventricular stroke work index
MAP ¼ mean arterial pressure
Tau ¼ time constant of ventricular relaxation




Eighteen LargeWhite–Landrace–Duroc piglets (weighing 9–12 kg, 4–6
weeks old) were initially anesthetized with intravenous ketamine hydro-
chloride (4 mg/kg). After endotracheal intubation, each piglet was venti-
lated with a volume-cycled respirator (PH-5F II; Acoma Medical
Industry Co, Ltd, Tokyo, Japan) using oxygen, air, and 1% to 1.5% sevo-
flurane, while maintaining carbon dioxide and pH within the normal range.
The electrocardiogram was recorded with surface electrodes.
A catheter was inserted into the left femoral vein to monitor central ve-
nous pressure, to infuse acetated Ringer solution and anesthetic intrave-
nously, and to withdraw blood samples. Both 0.3 mg/kg of pancuronium
bromide and 0.3 mL/kg of heparin sodium were infused. Another catheter
was placed in the left femoral artery to monitor arterial pressure.
After midline sternotomy, the pericardium was opened. LV dimensions
weremeasured in 2 axes (anterior–posterior and apex–base) by pairs of ultra-
sonic transducers that were positioned on the epicardial surface and secured
with purse-string sutures. A Millar Mikro-Tip catheter (Millar Instruments,
Inc, Houston, Tex) was inserted into the left ventricle through the apex for
measurement of the LV pressure. The ultrasonic crystals were attached to
a digital sonomicrometer (Sonometrics Corporation, London, Ontario, Can-
ada). LV pressure and data from the crystals weremonitored continuously on
line by computer and were intermittently recorded for off-line analysis.
A 12F arterial cannula was placed in the aortic arch via the right carotid
artery and a 24F cannula was placed in the right atrium. Then a snare was
passed around the inferior vena cava. An 8F cannula was advanced into the
left atrium through left atrial appendage for monitoring of left atrial pres-
sure (LAP) and for venting the left side of the heart during cardiac arrest.
Another 8F catheter was placed in the main pulmonary artery for additional
venting. An aortic root cannula with side branches for administration of
cardioplegic solution, pressure monitoring, and venting was inserted into
the aortic root.
The CPB circuit was primed with heparinized homologous whole blood
drawn from a donor pig, acetated Ringer solution, hydroxyethylated starch,
D-mannitol, and sodium bicarbonate, followed by hemoconcentration with
extracorporeal ultrafiltration to achieve an intrabypass hematocrit of 20%
to 25%. All hemodynamic parameters were monitored simultaneously on
a 6-channel polygraph system. A transit-time ultrasonic flow meter (T201;
Transonic System, Inc, Ithaca, NY) was intermittently placed around
the ascending aorta for measurement of cardiac output and data were
recorded simultaneously with central venous pressure, LAP, and arterial
pressure to calculate LV stroke work and to create LV function curves
for analysis.EExperimental Protocol
After heparinization (0.3 mL/kg), CPB was initiated at a flow rate of ap-
proximately 2.2 L $ min1 $ m–2. We used a pulsatile roller pumpThe Journal of Thoracic and Ca(Advanced Perfusion System 1; Terumo Corp, Tokyo, Japan) and a mem-
brane oxygenator (Capiox SX10; Terumo Corp). Arterial blood pressure
was maintained at 50 to 80 mm Hg, with the pH at 7.35 to 7.45, oxygen
tension greater than 300 mm Hg, carbon dioxide tension at 35 to 45 mm
Hg, and systemic normothermia.
The aortic crossclamp was applied and cardioplegic arrest was initiated
with 400 mL of St Thomas Hospital II solution (Miotector; Mochida Corp,
Japan) being infused within 3 minutes at an aortic root pressure of 50 to 80
mm Hg.
Then the heart was subjected to 90 minutes of global ischemia with top-
ical pericardial cooling (ice slush) and without any additional cardioplegic
solution.
No inotropic or vasoactive drugs were used. The heart was kept in the
empty beating state for 30 minutes after reperfusion, and then the piglet
was weaned from CPB. After postischemic cardiac function measure-
ments, blood sampling, and final tissue sampling, the animal died by exsan-
guination after removal of the heart under anesthesia.
Experimental Groups
The piglets were divided into the following groups (3 male and 3 female
were in each group) on the basis of the method of reperfusion (Figure 1).
Uncontrolled reperfusion group (control). In 6 piglets, the
crossclamp was simply removed, and the heart was reperfused at a perfu-
sion pressure of 50 to 70 mm Hg.
Postconditioning groups. Postconditioning 10 group. In 6
piglets, 6 cycles of unclamping and reclamping of the aorta for 10 seconds
each were performed over 2 minutes before complete removal of the cross-
clamp.
Postconditioning 30 group. In 6 piglets, 3 cycles of unclamping and
reclamping of the aorta for 30 seconds each over 3 minutes were performed
before complete removal of the crossclamp.
Myocardial Performance
LV pressure–volume loops were drawn from pressure data measured by
a Millar catheter-tip manometer and sonomicrometry data using a 2-axis
ellipsoidal model, while cardiac output was measured with a flow meter
at baseline and after 30 minutes of reperfusion. A series of pressure–vol-
ume loops was generated through transient occlusion of the inferior vena
cava by tightening and releasing the tape snare during an 8-second period
of apnea. Post hoc analysis of cardiac function was done with the Sonomet-
rics software package.
LV contractility. LV contractility was assessed from the descending
slope of the end-systolic pressure–volume relationship by linear regression
analysis and was designated as end-systolic elastance (Ees).
Diastolic function. The time constant of ventricular relaxation (Tau)
was calculated from the decline of the LV pressure trace at a stable LVEDV
during isovolumic relaxation.
Ees and Tau values measured after reperfusion were expressed as a per-
centage of the respective baseline values.
Global Cardiac Performance From the LV Function
Curve
Integrated myocardial performance was evaluated by calculating
the LV stroke work index (LVSWI) after infusing blood through the
arterial cannula and simultaneously recording the mean arterial pres-
sure (MAP), LAP, and heart rate (HR), as well as measuring cardiac
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where BW is body weight.rdiovascular Surgery c Volume 142, Number 4 927
FIGURE 1. Experimental protocols of the different groups. All piglets were subjected to 90 minutes of cardioplegic arrest under cardiopulmonary
bypass (CPB). In the control group, there was no intervention before 30 minutes of reperfusion. The postconditioning (Post-con) groups received 6 cycles
of 10 seconds (s) of reperfusion/10 seconds of ischemia (Post-con 10) or 3 cycles of 30 seconds of reperfusion/30 seconds of ischemia (Post-con 30) at the
start of 30 minutes of reperfusion. Cardiac function was measured before CPB and at 30 minutes after reperfusion just after weaning from CPB.




SVentricular function curves were drawn by plotting LAP (x axis) versus
LVSWI (y axis). Then linear regression analysis was performed and the
area of the trapezoid between the regression lines for minimum and max-
imumLAPs obtained before and after CPBwas calculated. Recovery of LV
performance was assessed by calculating the area of the trapezoid after
reperfusion as a percentage of the baseline value (Figure 2).
Biochemical Parameters
Plasma troponin-T. Arterial blood samples were taken before initi-
ation of CPB, at the end of ischemia, and after 15 and 30 minutes of reper-
fusion. Biochemical myocardial injury was determined by measuring the
plasma troponin-T level using the electrochemiluminescent immunoassay
method.FIGURE 2. Ventricular function curves were created by plotting left atrial p
(y axis), and linear regression lines were drawn. The area of the trapezoid betwee
and after cardiopulmonary bypass was defined as the area under the left ventri
928 The Journal of Thoracic and Cardiovascular SurgTissue lipid peroxide. Transmural samples of the right ventricular
free wall were taken before initiation of CPB, at the end of ischemia,
and after 30 minutes of reperfusion. These samples were frozen and stored
at80C until assay.
Then the lipid peroxide content of tissue homogenates was measured by
the methylene blue–hemoglobin method.
Statistics
Continuous variables are expressed as the mean  standard deviation.
One-factor factorial analysis of variance or 1-factor repeated-measures
analysis of variance was performed to assess the statistical significance of
differences in discrete or continuous variables among the groups, respec-
tively. If a significant F ratio was obtained, further analysis was carriedressure (LAP) (x axis) versus left ventricular stroke work index (LVSWI)
n the regression lines for the minimum and maximumLAP obtained before
cular function curve.
ery c October 2011




The results are presented in Figure 3.
Ees. In the control group, there was a marked decrease of
Ees after 30 minutes of reperfusion to 46.1%  7.1% of
the baseline value, indicating LV contractile dysfunction.
In contrast, there was significantly better recovery of Ees
in both the postconditioning groups (89.2%  33.5% in
the postconditioning 10 group [P< .05] and 118.2% 
20.3% in the postconditioning 30 group [P<.01], respec-
tively).
Tau. The control group showed severe increase of Tau after
30 minutes of reperfusion among all of the groups (218.5%
 49.7% of baseline value), indicating diastolic dysfunc-
tion. In the postconditioning groups, the increase of Tau
was significantly smaller (142.3% 50.4% in the postcon-
ditioning 10 group [P<.05] and 120.4%  25.3% in the
postconditioning 30 group [P<.01]).
Global LV Performance
In the control group, the LV function curve area after
30 minutes of reperfusion was 28.6%  4.0% of baseline,FIGURE 3. (A) End-systolic elastance (Ees), (B) time constant of isovolumic r
minutes of reperfusion. Each parameter is shown as the percent recovery from th
mean. *P<.05, **P<.01 versus control group. There are no significant differenc
statically significant, but marginally significant, improvement of LVSWI in the p
Not significant.
The Journal of Thoracic and Caindicating severe hemodynamic impairment attributable to
LV systolic and diastolic dysfunction. In the postcondition-
ing 30 group, there was significant improvement of the
curve area compared with the control group (69.4% 
28.4%; P< .05), indicating that the protective effect on
LV performance resulted from both systolic and diastolic
functional recovery. In the postconditioning 10 group, a ten-
dency to improvement of LVSWI was shown with marginal
significance (P ¼ .084).Biochemical Parameters
The profile of plasma troponin-T levels over time is pre-
sented in Figure 4. There was a marked increase of
troponin-T after reperfusion in the control group (2.54 
0.81 ng/mL), whereas troponin-T was significantly lower
after 30 minutes of reperfusion in the postconditioning 10
group (0.58  0.25 ng/mL; P<.05 vs all groups). In the
postconditioning 30 group, however, a reduction of
troponin-T was not seen, despite better functional recovery
in this group (1.85 0.4 ng/mL). Right ventricular myocar-
dial lipid peroxide levels are presented in Table 1.
There were no significant differences of lipid peroxide
levels before CPB and after 90 minutes of ischemia among
the 3 groups. Therewas a dramatic increase of lipid peroxideelaxation (Tau), (C) and left ventricular stroke work index (LVSWI) after 30
e preischemic value. Data are reported as the mean standard error of the
es in Ees, Tau, and LVSWI between 2 postconditioning groups. There is not
ostconditioning (Post-con) 10 group compared with control (P¼ .084). NS,





FIGURE 4. Changes of the plasma troponin-T levels. Post-con, Postcon-
ditioning; NS, not significant; R, reperfusion. *P<.05 versus all groups.




Safter reperfusion in the control group (199%  56% of the
value after 90 minutes of ischemia). The increase of lipid
peroxide after 30 minutes of reperfusion (as a percentage
of the value at the end of ischemia) was significantly smaller
in both the postconditioning groups compared with the
control group (112%  39% for postconditioning 10 and
131%  10% for postconditioning 30).DISCUSSION
In the present study, we demonstrated that performance
of ischemic postconditioning before complete aortic un-
clamping led to improved postbypass LV performance in
piglets after cardioplegic arrest. Postconditioning amelio-
rated LV contractile dysfunction and isovolumic diastolic
dysfunction, leading to restoration of nearly normal global
LV performance, along with the reduction of myocardial
lipid peroxide levels (an indicator of cellular oxidative
injury).
Previous studies in coronary artery occlusion–reperfu-
sion models have shown that postconditioning ameliorates
multiple manifestations of ischemia–reperfusion injury,
including a reduction of infarct size and endothelial dys-
function.1,2,7
Nevertheless, the effect of postconditioning on myocar-
dial dysfunction remains controversial. Studies of in vivo
coronary ligation models in various species have revealed
a universal protective effect against myocardial infarctionTABLE 1. Myocardial lipid peroxide level after 30 minutes of
reperfusion.
Control Post-con 10 Post-con 30
Pre (ng/mL) 0.0183  0.0082 0.0296  0.0267 0.0140  0.0015
Ischemia
90 (ng/mL)
0.0195  0.0096 0.0269  0.0187 0.0144  0.0012
Reperfusion
30 (ng/mL)
0.0382  0.0213 0.0247  0.0038 0.0191  0.0026
R30/I90 (%) 199.75  56.3* 112.18  39.1*,y 131.96  10.0*
R30/I90, Value at 30 minutes after reperfusion expressed as percentage of the
90-minute ischemia value (measured just before reperfusion). *P<.05 versus control
group. yThere is no significant difference between the 2 postconditioning groups.
930 The Journal of Thoracic and Cardiovascular Surgbut have found no protective effect against depression of
hemodynamic parameters (MAP, rate pressure product,
and LVEDP), global myocardial dysfunction (LVEDP,
þdP/dt,dP/dt), or impaired regional wall motion (systolic
shortening and segmental work) in dogs,1 rats,2 and rab-
bits.5 Furthermore, experiments with a short ischemic
period of 10 minutes for stunning have shown that ische-
mic postconditioning does not change the depression of
LV wall thickening (in dogs) or segmental shortening (in
rabbits) over 3 to 24 hours after reperfusion.3 In contrast
to these studies on models of regional ischemia, recent ex-
perimental studies of isolated rat hearts subjected to global
ischemia demonstrated that postconditioning can improve
LV dysfunction based on LV pressure data (þdP/dt,
LVEDP, and recovery of developed LV pressure).4,6
However, unlike the protective effect on ventricular
contracture that is well correlated with the reduction of
infarct size, the beneficial effect on postischemic systolic
dysfunction was reported to show no clear relation to the
effect on infarction.
Previous clinical investigations of postconditioning in
patients undergoing cardiac surgery in China did not obtain
any data on cardiac function.8,9
The main mediators and effectors involved in the mecha-
nism of postconditioning are reported to be adenosine,10-14
nitric oxide,15 a reperfusion injury salvage kinase pathway
(phosphatidylinosito l3-kinase and extracellular signal-
regulated kinase),15,16 opening of mitochondrial potassium
adenosine triphosphate channels,5 and prevention of the mi-
tochondrial permeability transition,17 which is a crucial
event in reperfusion injury triggered by Ca2þ overload and
excessive production of reactive oxygen species.18,19
Cyclosporine A, a specific mitochondrial permeability
transition inhibitor, has been demonstrated by Oka and
associates20 to prevent mitochondrial dysfunction and im-
prove myocardial performance (including both systolic
and diastolic function) after cardioplegic arrest in isolated
rat hearts.
In the present study, both postconditioning algorithms
similarly reduced the myocardial lipid peroxide content af-
ter 30 minutes of reperfusion, indicating that one of the ef-
fectors of ischemia–reperfusion injury was attenuated,
although the actual protective effect was dissimilar.
Previous studies on the protective effect of postcondition-
ing against myocardial infarction in other animal models
suggested that (1) the infarct-sparing effect differs among
species2,5,7 and also between genders4 and (2) the postcon-
ditioning, particularly in length of ischemia and reperfu-
sion, rather than number of cycles, is species dependent.
Several extended algorithms with 3 cycles of 30-second re-
perfusion and 30-second reocclusion have been applied in
dog and rabbit models,5,7 whereas 4 cycles of reperfusion
and reocclusion for 1 minute each were tested in dogs and
rabbits by Couvreur and colleagues.3ery c October 2011




SIn the present study, 2 postconditioning protocols exam-
ined showed disparate protective effects on biochemical in-
jury and myocardial dysfunction. In the postconditioning 10
group, limitation of biochemical injury was associated with
recovery of myocardial systolic and diastolic function. On
the other hand, in the postconditioning 30 group, myocar-
dial functional recovery was prominent with 70% of base-
line global function being restored despite lack of reduction
in troponin-T release. In the isolated heart model, myocar-
dial contracture may be mainly due to myocardial infarc-
tion, while recovery of contractile function may depend
on alleviation of both myocardial necrosis and stunning.4
In addition, functional recovery after cardioplegic arrest is
thought to be influenced by myocardial metabolism, which
had to recover from an ischemic period characterized by
minimum oxygen consumption in our model, unlike global
ischemia without cardioplegia or normothermic regional is-
chemia in a coronary ligation model.
The different functional and biochemical outcomes ob-
tained with our 2 postconditioning algorithms indicate
that the pattern of repeated ischemic insults may determine
the influence on the cellular energy status, resulting in re-
versible metabolic depression or moderate injury and irre-
versible change. After the derangement of metabolism
caused by cardioplegic arrest, repeated brief ischemic in-
sults (postconditioning 10) were protective against irrevers-
ible myocardial injury but failed to promote prompt
functional recovery.
On the other hand, more intensive ischemic stimulation
(postconditioning 30) also attenuated myocardial lipid per-
oxide and improved cellular metabolic recovery compared
with the control group, although enzyme release was aggra-
vated.
The excessively great recovery of Ees exceeding baseline
value up to 118.2%  20.3% seen in the postconditioning
30 group is difficult to understand. One possibility is spec-
ulated that either energy metabolic efficacy including ino-
tropic response or activation-contraction coupling or other
would be supranormally stimulated in viable myocardium,
based on the independence of Ees from cardiac preload
and afterload, evident myocardial cell injury from troponin
T release, and association with improvement of Tau.
Whether it is a phenomenon similar to hypercontraction,
as seen in nonischemic areas in myocardial infarction, is un-
known because of lack of wall motion analysis. As another
possible explanation, by the remote postconditioning ef-
fect,21,22 interaction of neurohormonal factor such as
norepinephrine overflow between the heart and a remote
organ may be involved in our in vivo model.
Limitations
In this study, tissue lipid peroxide was measured in the
right ventricular myocardium to allow repeated sampling
(3 times per experiment). Inasmuch as there was a decreaseThe Journal of Thoracic and Caof lipid peroxide in absolute terms after reperfusion, mea-
surement of LV tissue after reperfusion would also be appli-
cable for comparing the groups.
An ischemia–reperfusion protocol with 90 minutes of is-
chemia and a single dose of cardioplegic solution, which
has been demonstrated to induce severe impairment of myo-
cardial performance (cardiac function curve area of 28% in
the control group) was examined in this study. In the surgi-
cal setting, repeated administration of crystalloid or blood
cardioplegic solution will minimize ischemia–reperfusion
injury in most cases. However, the protective effect of
postconditioning observed in this study could be valuable
for emergency ‘‘rescue’’ therapy in the situation of
unexpectedly prolonged cardioplegic arrest or inadequate
cardioprotection.
Inasmuch as multidose blood cardioplegia is widely used
because of its superior preservation of myocardial aerobic
metabolism and high-energy phosphate stores in cardiac
surgery, whether postconditioning would be beneficial for
attenuation of ischemia–reperfusion injury after multidose
blood cardioplegia remains to be determined.
Although postconditioning is a fairly simple and repro-
ducible procedure as regards implementation of principles
of several brief cycles of reperfusion and ischemia, repeti-
tive manipulation of the aortic crossclamp performed in
our study increases the risk of aortic dissection and crucial
embolism in clinical cardiac surgery, particularly for the pa-
tient with a fragile or calcified aorta or mobile plaque in the
aorta. Therefore, the technical modification to improve the
safety of the surgical postconditioning procedure, such as
alternating between normal blood infusion and intermission
by the use of blood cardioplegic delivery system before aor-
tic unclamping, would be necessary.
CONCLUSIONS
Postconditioning was demonstrated to have a protective
effect against myocardial dysfunction after cardioplegic ar-
rest in piglets with or without the limitation of biochemical
injury according to algorism. However, investigation of
postconditioning in a multidose blood cardioplegic arrest
model and improvement of the procedure are needed before
clinical application.
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